Thomssen C - Search Results

1

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024.

Thill M, Janni W, Albert US, Banys-Paluchowski M, Bauerfeind I, Blohmer J, Budach W, Dall P, Ditsch N, Fallenberg EM, Fasching PA, Fehm T, Friedrich M, Gerber B, Gluz O, Harbeck N, Hartkopf A, Heil J, Huober J, Jackisch C, Kolberg-Liedtke C, Kreipe HH, Krug D, Kühn T, Kümmel S, Loibl S, Lüftner D, Lux MP, Maass N, Mundhenke C, Reimer T, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Schütz F, Sinn HP, Solbach C, Solomayer EF, Stickeler E, Thomssen C, Untch M, Witzel I, Wöckel A, Würstlein R, Müller V, Park-Simon TW. Thill M, et al. Among authors: thomssen c. Breast Care (Basel). 2024 Jun;19(3):183-191. doi: 10.1159/000538753. Epub 2024 Apr 10. Breast Care (Basel). 2024. PMID: 38894953 Free article. Review.

2

Preliminary results of a phase II study of epirubicin and paclitaxel as first-line treatment in patients with metastatic breast cancer.

Lück HJ, Thomssen C, du Bois A, Lisboa BW, Untch M, Kühnle H, Jänicke F, Meerpohl HG, Lindner C, Konecny G, Hecker D, Diergarten K. Lück HJ, et al. Among authors: thomssen c. Semin Oncol. 1997 Feb;24(1 Suppl 3):S13-6. Semin Oncol. 1997. PMID: 9071334 Clinical Trial.

3

Paclitaxel and epirubicin as first-line therapy for patients with metastatic breast cancer.

Lück HJ, Du Bois A, Thomssen C, Lisboa B, Untch M, Köhler G, Hecker D. Lück HJ, et al. Among authors: thomssen c. Oncology (Williston Park). 1997 Apr;11(4 Suppl 3):34-7. Oncology (Williston Park). 1997. PMID: 9144689 Free article. Clinical Trial.

4

Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer.

Lück HJ, Thomssen C, du Bois A, Untch M, Lisboa B, Köhler G, Diergarten K. Lück HJ, et al. Among authors: thomssen c. Semin Oncol. 1997 Oct;24(5 Suppl 17):S17-35-S17-39. Semin Oncol. 1997. PMID: 9374090 Clinical Trial.

5

Metastatic breast cancer: experience with the combination paclitaxel plus epirubicin.

Lück HJ, Thomssen C, Du Bois A, Untch M, Lisboa B, Köhler G, Diergarten K. Lück HJ, et al. Among authors: thomssen c. Oncology (Williston Park). 1998 Jan;12(1 Suppl 1):36-9. Oncology (Williston Park). 1998. PMID: 9516602 Free article.

6

Identification of low-risk node-negative breast cancer patients by tumor biological factors PAI-1 and cathepsin L.

Thomssen C, Oppelt P, Jänicke F, Ulm K, Harbeck N, Höfler H, Kuhn W, Graeff H, Schmitt M. Thomssen C, et al. Anticancer Res. 1998 May-Jun;18(3C):2173-80. Anticancer Res. 1998. PMID: 9703780

7

Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.

Jänicke F, Prechtl A, Thomssen C, Harbeck N, Meisner C, Untch M, Sweep CG, Selbmann HK, Graeff H, Schmitt M; German N0 Study Group. Jänicke F, et al. Among authors: thomssen c. J Natl Cancer Inst. 2001 Jun 20;93(12):913-20. doi: 10.1093/jnci/93.12.913. J Natl Cancer Inst. 2001. PMID: 11416112 Clinical Trial.

8

Clinical utility of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 determination in primary breast cancer tissue for individualized therapy concepts.

Harbeck N, Schmitt M, Kates RE, Kiechle M, Zemzoum I, Jänicke F, Thomssen C. Harbeck N, et al. Among authors: thomssen c. Clin Breast Cancer. 2002 Aug;3(3):196-200. doi: 10.3816/CBC.2002.n.023. Clin Breast Cancer. 2002. PMID: 12196277 Review.

9

[u-Plasminogen activator (urinary plasminogen activator, urokinase) (uPA) and its PA-1 type 1 inhibitor are not only prognostically but also predictively significant and support clinical decisions on therapy in primary carcinoma of the breast].

Harbeck N, Thomssen C. Harbeck N, et al. Among authors: thomssen c. Zentralbl Gynakol. 2003 Sep;125(9):362-7. doi: 10.1055/s-2003-43036. Zentralbl Gynakol. 2003. PMID: 14569518 German.

10

Clinical relevance of prognostic factors in axillary node-negative breast cancer.

Thomssen C, Jänicke F, Harbeck N. Thomssen C, et al. Onkologie. 2003 Oct;26(5):438-45. doi: 10.1159/000072976. Onkologie. 2003. PMID: 14605459 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

345 results

Search Page

Filters